Results 181 to 190 of about 19,419,888 (317)
Decision-driven analytics: Leveraging human intelligence to unlock the power of data
Companies have more data at their fingertips than ever before. Yet, studies show that many executives and organizations fail to extract real value from it.
De Langhe, Bart, Puntoni, Stefano
core
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena +15 more
wiley +1 more source
Circulating tumor cells (CTCs) and plasma cell‐free DNA (cfDNA) were analyzed to detect ESR1 mutations and methylation in patients with advanced breast cancer. CTC‐derived DNA showed higher sensitivity for mutation detection and revealed complementary genetic and epigenetic alterations, highlighting the added value of CTC analysis for understanding ...
Dimitra Stergiopoulou +12 more
wiley +1 more source
The Evolution of Data-Driven Management Zone Delineation: A Systematic Review. [PDF]
Heidari R, Khanmohammadi R, Samavati FF.
europepmc +1 more source
Explore the anti-competitive and pro-competitive aspects generated by data-driven mergers.
openNel seguente lavoro vengono analizzati gli effetti che le acquisizioni o fusioni guidate dai dati, definite data-driven mergers, hanno sulla concorrenza, siano essi effetti che la favoriscono o che la indeboliscono, si propone anche un'analisi su ...
ZANARDO, MARCO
core
Interpreting the effects of DNA polymerase variants at the structural level
Using MAVISp and molecular dynamics simulations, we analyzed over 60 000 missense variants in POLE and POLD1 from ClinVar, COSMIC, cBioPortal, and saturation mutagenesis. Identified mechanistic indicators, including stability, binding, and long‐range, enable structural interpretation, providing ACMG‐like evidence for possible reclassification of VUS ...
Matteo Arnaudi +7 more
wiley +1 more source
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata +10 more
wiley +1 more source
The brain network underlying social participation: a multimodal, data-driven investigation. [PDF]
Casburn MG +9 more
europepmc +1 more source
Discovering Emergent Shapes Using a Data-Driven Symbolic Model
This paper presents a model for discovering emergent shapes based on the concept of shape hiding and data-driven search. It is founded on representing polyline bounded shapes using infinite maximal lines, an extension of the concept of maximal lines.
Min Yan +3 more
core
Dormant cancer cells can hide in distant organs for years, evading treatment and the immune system. This review highlights how signals from the surrounding tissue and immune environment keep these cells inactive or trigger their reawakening. Understanding these mechanisms may help develop therapies to eliminate or control dormant cells and prevent ...
Kanishka Tiwary +1 more
wiley +1 more source

